10x Genomics, Inc.

NASDAQ:TXG

22.08 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 618.727516.409490.49298.845245.893146.31371.085
Cost of Revenue 209.414120.38674.09158.46861.03328.66110.56
Gross Profit 409.313396.023416.399240.377184.86117.65260.525
Gross Profit Ratio 0.6620.7670.8490.8040.7520.8040.851
Reseach & Development Expenses 270.332265.667211.752123.37583.09747.53732.164
General & Administrative Expenses 337.549294.6252.86200.426129.33487.23646.536
Selling & Marketing Expenses 3.33.74.71.91.50.70.2
SG&A 340.849298.3257.56202.326130.83487.93646.736
Other Expenses -0.307-0.198-0.8021.337-0.186-0.2490.137
Operating Expenses 611.181563.967469.312325.701213.931135.47378.9
Operating Income -201.868-167.944-52.913-85.324-29.071-110.764-18.375
Operating Income Ratio -0.326-0.325-0.108-0.286-0.118-0.757-0.258
Total Other Income Expenses Net -46.8955.973-0.802-449.152-1.962-93.1920.137
Income Before Tax -248.763-161.971-53.715-534.476-31.033-112.398-18.741
Income Before Tax Ratio -0.402-0.314-0.11-1.788-0.126-0.768-0.264
Income Tax Expense 6.3364.0294.5088.2550.2180.0870.021
Net Income -255.099-166-58.223-542.731-31.251-112.485-18.762
Net Income Ratio -0.412-0.321-0.119-1.816-0.127-0.769-0.264
EPS -2.18-1.46-0.53-5.37-0.8-8.4-1.62
EPS Diluted -2.18-1.46-0.53-5.37-0.8-8.4-1.62
EBITDA -158.249-161.495-53.509-82.455-26.452-13.141-13.625
EBITDA Ratio -0.256-0.313-0.109-0.276-0.108-0.09-0.192